Cigna Corp (CI) Stock Analysis

CI- NYSE (USA) Also traded in: Germany
Cigna Corp

Currently 3.5/5

Business Predictability Rank: 3.5-Star (On Watch)
Back Testing Results:
Average gain of all 3.5-Star stocks: 9.3% per year.
% of Stocks that are in still loss if held for 10yrs: 9%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$148.14

0(0%) Volume: 2,312,726 1:01AM EST

Avg Vol (1m): 1,291,016

3 Medium Warning Signs 2 Good Signs

Market Cap	38.05 B	P/E(ttm)	20.13
Enterprise Value	38.68 B	P/B	2.75

$148.14 (1y: +14%)

RSS

Manual of Stocks™ Web APP

Manual of Stocks™

Sorry. Only PremiumPlus Member can access this feature.

Free Trial

Also traded in: Germany

Financial Strength : 6/10

		vs industry	vs history
Cash to Debt	0.64	NYSE:CI's Cash to Debt is ranked lower than 64% of the 25 Companies in the Global Health Care Plans industry. ( Industry Median: 1.36 vs. NYSE:CI: 0.64 ) Ranked among companies with meaningful Cash to Debt only.	NYSE:CI' s Cash to Debt Range Over the Past 10 Years Min: 0.28 Med: 0.7 Max: N/A Current: 0.64
Equity to Asset	0.23	NYSE:CI's Equity to Asset is ranked lower than 72% of the 25 Companies in the Global Health Care Plans industry. ( Industry Median: 0.32 vs. NYSE:CI: 0.23 ) Ranked among companies with meaningful Equity to Asset only.	NYSE:CI' s Equity to Asset Range Over the Past 10 Years Min: 0.05 Med: 0.12 Max: 0.23 Current: 0.23 0.05 - 0.23
Interest Coverage	12.13	NYSE:CI's Interest Coverage is ranked higher than 58% of the 24 Companies in the Global Health Care Plans industry. ( Industry Median: 9.06 vs. NYSE:CI: 12.13 ) Ranked among companies with meaningful Interest Coverage only.	NYSE:CI' s Interest Coverage Range Over the Past 10 Years Min: 8.06 Med: 11.95 Max: N/A Current: 12.13

F-Score: 6
M-Score: -2.67
WACC vs ROIC	5.19% 12.63% WACC ROIC

Profitability & Growth : 8/10

		vs industry	vs history
Operating margin (%)	7.73	NYSE:CI's Operating margin (%) is ranked higher than 80% of the 25 Companies in the Global Health Care Plans industry. ( Industry Median: 4.16 vs. NYSE:CI: 7.73 ) Ranked among companies with meaningful Operating margin (%) only.	NYSE:CI' s Operating margin (%) Range Over the Past 10 Years Min: 2 Med: 8.68 Max: 10.46 Current: 7.73 2 - 10.46
Net-margin (%)	4.87	NYSE:CI's Net-margin (%) is ranked higher than 80% of the 25 Companies in the Global Health Care Plans industry. ( Industry Median: 2.45 vs. NYSE:CI: 4.87 ) Ranked among companies with meaningful Net-margin (%) only.	NYSE:CI' s Net-margin (%) Range Over the Past 10 Years Min: 1.53 Med: 5.89 Max: 7.07 Current: 4.87 1.53 - 7.07
ROE (%)	14.97	NYSE:CI's ROE (%) is ranked higher than 70% of the 23 Companies in the Global Health Care Plans industry. ( Industry Median: 11.62 vs. NYSE:CI: 14.97 ) Ranked among companies with meaningful ROE (%) only.	NYSE:CI' s ROE (%) Range Over the Past 10 Years Min: 7 Med: 19.03 Max: 28.9 Current: 14.97 7 - 28.9
ROA (%)	3.26	NYSE:CI's ROA (%) is ranked lower than 56% of the 25 Companies in the Global Health Care Plans industry. ( Industry Median: 3.81 vs. NYSE:CI: 3.26 ) Ranked among companies with meaningful ROA (%) only.	NYSE:CI' s ROA (%) Range Over the Past 10 Years Min: 0.72 Med: 2.81 Max: 3.81 Current: 3.26 0.72 - 3.81
Revenue Growth (3Y)(%)	13.70	NYSE:CI's Revenue Growth (3Y)(%) is ranked higher than 59% of the 22 Companies in the Global Health Care Plans industry. ( Industry Median: 10.60 vs. NYSE:CI: 13.70 ) Ranked among companies with meaningful Revenue Growth (3Y)(%) only.	NYSE:CI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years Min: -2.2 Med: 10.8 Max: 18.4 Current: 13.7 -2.2 - 18.4
EBITDA Growth (3Y)(%)	12.50	NYSE:CI's EBITDA Growth (3Y)(%) is ranked higher than 60% of the 20 Companies in the Global Health Care Plans industry. ( Industry Median: 11.60 vs. NYSE:CI: 12.50 ) Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.	NYSE:CI' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years Min: -24.3 Med: 9.6 Max: 57.7 Current: 12.5 -24.3 - 57.7
EPS Growth (3Y)(%)	12.70	NYSE:CI's EPS Growth (3Y)(%) is ranked higher than 58% of the 19 Companies in the Global Health Care Plans industry. ( Industry Median: 10.80 vs. NYSE:CI: 12.70 ) Ranked among companies with meaningful EPS Growth (3Y)(%) only.	NYSE:CI' s EPS Growth (3Y)(%) Range Over the Past 10 Years Min: -32 Med: 6.2 Max: 64.6 Current: 12.7 -32 - 64.6

GuruFocus has detected 3 Warning Signs with Cigna Corp $NYSE:CI.

More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

» NYSE:CI's 10-Y Financials

Financials (Next Earnings Date: 2017-05-05)

Revenue & Net Income

Equity & Asset

Oprt. Cash Flow & Free Cash Flow

Oprt. Cash Flow & Net Income

» NYSE:CI's Warning Signs

Warning Signs

Subscribe to see Warning Signs. .

Start your free trial

» Details

Guru Trades

Q1 2016

Q2 2016

Q3 2016

Q4 2016

» Details

Insider Trades

Latest Guru Trades with CI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Select Gurus: | Basic | Premium

| Premium Plus

No Entry found in the selected group of Gurus. You can

1. Modify your Personalized List of Gurus, or
2. Click on Premium above to check out all the Gurus, or
3. Click on Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry:	Health Care Plans » Health Care Plans NAICS: 524114 SIC: 6324
Compare:	NAS:ESRX, NYSE:AET, NYSE:HUM, NYSE:ANTX, NYSE:CNC, NYSE:WCG, NYSE:MOH, NAS:MGLN, NYSE:UAM, NAS:HIIQ, NAS:CNXR, OTCPK:WCUI, OTCPK:OPRX, NYSE:CVS, NYSE:UNH » details
Traded in other countries:	CGN.Germany,

Cigna Corp is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services.

Cigna Corp was incorporated in Delaware in 1981. The Company is a health services organization. It offers a differentiated set of medical, dental, disability, life and accident insurance and related products and services. The Company operates in four reportable segments Global Health Care; Global Supplemental Benefits; Group Disability and Life; Other Operations. The Global Health Care aggregates the Commercial and Government operating segments. The Commercial operating segment encompasses both the U.S. commercial and certain international health care businesses serving employers and their employees, other groups, and individuals. Products and services include medical, dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs and other products and services to insured and self-insured customers. The Government operating segment offers Medicare Advantage and Medicare Part D plans to seniors and Medicaid plans. Global Supplemental Benefits offers supplemental health, life and accident insurance products in selected international markets and in the U.S. Group Disability and Life provides group long-term and short-term disability, group life, accident and specialty insurance products and related services. The Other Operations segment includes the results from the run-off reinsurance and settlement annuity businesses, as well as the remaining deferred gains recognized from the sale of the individual life insurance and annuity and retirement benefits businesses. The Commercial operating segment, either directly or through its partners, offers some or all of its products in all 50 states, the District of Columbia, the U.S. Virgin Islands, Canada, Europe, the Middle East, and Asia. It offers a variety of medical plans including - Managed Care Plans including HMO, Network, Network Open Access and Open Access Plus; PPO Plans; and Choice Fund Suite of Consumer-Driven Products. Its government health plans includes Medicare Advantage; Medicare Part D; and Medicaid. The Company offers health care and related products and services in the following customer segments or markets - national; middle market; select, individual; government; and international. The Company's competitors in U.S.-based health care businesses include other national insurance and health services companies that provide group health and life insurance products; not for profit managed care organizations; other regional stand-alone managed care and specialty companies; managed care organizations affiliated with insurance companies and hospitals; and national managed pharmacy, behavioral health and utilization review services companies. Its competitors in the international health care business include U.S. and other health insurance companies with health benefits operations.

Ratios

		vs industry	vs history
P/E(ttm)	20.13	CI's P/E(ttm) is ranked higher than 55% of the 20 Companies in the Global Health Care Plans industry. ( Industry Median: 20.33 vs. CI: 20.13 ) Ranked among companies with meaningful P/E(ttm) only.	CI' s P/E(ttm) Range Over the Past 10 Years Min: 3.25 Med: 12.62 Max: 21.1 Current: 20.13 3.25 - 21.1
Forward P/E	15.55	CI's Forward P/E is ranked lower than 67% of the 9 Companies in the Global Health Care Plans industry. ( Industry Median: 13.66 vs. CI: 15.55 ) Ranked among companies with meaningful Forward P/E only.	N/A
PE(NRI)	20.13	CI's PE(NRI) is ranked higher than 55% of the 20 Companies in the Global Health Care Plans industry. ( Industry Median: 20.33 vs. CI: 20.13 ) Ranked among companies with meaningful PE(NRI) only.	CI' s PE(NRI) Range Over the Past 10 Years Min: 3.25 Med: 12.66 Max: 21.1 Current: 20.13 3.25 - 21.1
Price/Owner Earnings (ttm)	10.37	CI's Price/Owner Earnings (ttm) is ranked higher than 56% of the 16 Companies in the Global Health Care Plans industry. ( Industry Median: 10.92 vs. CI: 10.37 ) Ranked among companies with meaningful Price/Owner Earnings (ttm) only.	CI' s Price/Owner Earnings (ttm) Range Over the Past 10 Years Min: 2.21 Med: 10.28 Max: 541.12 Current: 10.37 2.21 - 541.12
P/B	2.75	CI's P/B is ranked lower than 65% of the 23 Companies in the Global Health Care Plans industry. ( Industry Median: 2.49 vs. CI: 2.75 ) Ranked among companies with meaningful P/B only.	CI' s P/B Range Over the Past 10 Years Min: 0.52 Med: 2.22 Max: 3.96 Current: 2.75 0.52 - 3.96
P/S	0.95	CI's P/S is ranked lower than 76% of the 25 Companies in the Global Health Care Plans industry. ( Industry Median: 0.52 vs. CI: 0.95 ) Ranked among companies with meaningful P/S only.	CI' s P/S Range Over the Past 10 Years Min: 0.13 Med: 0.68 Max: 1.2 Current: 0.95 0.13 - 1.2
PFCF	11.05	CI's PFCF is ranked higher than 53% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 11.11 vs. CI: 11.05 ) Ranked among companies with meaningful PFCF only.	CI' s PFCF Range Over the Past 10 Years Min: 1.81 Med: 13.76 Max: 130.79 Current: 11.05 1.81 - 130.79
POCF	9.59	CI's POCF is ranked higher than 53% of the 19 Companies in the Global Health Care Plans industry. ( Industry Median: 9.67 vs. CI: 9.59 ) Ranked among companies with meaningful POCF only.	CI' s POCF Range Over the Past 10 Years Min: 1.52 Med: 10.36 Max: 48.76 Current: 9.59 1.52 - 48.76
EV-to-EBIT	11.76	CI's EV-to-EBIT is ranked higher than 55% of the 20 Companies in the Global Health Care Plans industry. ( Industry Median: 12.87 vs. CI: 11.76 ) Ranked among companies with meaningful EV-to-EBIT only.	CI' s EV-to-EBIT Range Over the Past 10 Years Min: -2.6 Med: 8.15 Max: 18 Current: 11.76 -2.6 - 18
EV-to-EBITDA	10.01	CI's EV-to-EBITDA is ranked lower than 52% of the 21 Companies in the Global Health Care Plans industry. ( Industry Median: 9.70 vs. CI: 10.01 ) Ranked among companies with meaningful EV-to-EBITDA only.	CI' s EV-to-EBITDA Range Over the Past 10 Years Min: -2.3 Med: 6.8 Max: 11.2 Current: 10.01 -2.3 - 11.2
PEG	1.28	CI's PEG is ranked higher than 58% of the 12 Companies in the Global Health Care Plans industry. ( Industry Median: 1.35 vs. CI: 1.28 ) Ranked among companies with meaningful PEG only.	CI' s PEG Range Over the Past 10 Years Min: 0.24 Med: 0.76 Max: 11.78 Current: 1.28 0.24 - 11.78
Shiller P/E	26.93	CI's Shiller P/E is ranked higher than 54% of the 13 Companies in the Global Health Care Plans industry. ( Industry Median: 27.14 vs. CI: 26.93 ) Ranked among companies with meaningful Shiller P/E only.	CI' s Shiller P/E Range Over the Past 10 Years Min: 3.12 Med: 16.11 Max: 33.81 Current: 26.93 3.12 - 33.81

Dividend & Buy Back

		vs industry	vs history
Dividend Yield	0.03	CI's Dividend Yield is ranked lower than 100% of the 26 Companies in the Global Health Care Plans industry. ( Industry Median: 2.35 vs. CI: 0.03 ) Ranked among companies with meaningful Dividend Yield only.	CI' s Dividend Yield Range Over the Past 10 Years Min: 0.02 Med: 0.08 Max: 0.57 Current: 0.03 0.02 - 0.57
Dividend Payout	0.01	CI's Dividend Payout is ranked higher than 92% of the 12 Companies in the Global Health Care Plans industry. ( Industry Median: 0.30 vs. CI: 0.01 ) Ranked among companies with meaningful Dividend Payout only.	CI' s Dividend Payout Range Over the Past 10 Years Min: 0.01 Med: 0.01 Max: 0.04 Current: 0.01 0.01 - 0.04
Forward Dividend Yield	0.03	CI's Forward Dividend Yield is ranked lower than 100% of the 24 Companies in the Global Health Care Plans industry. ( Industry Median: 2.36 vs. CI: 0.03 ) Ranked among companies with meaningful Forward Dividend Yield only.	N/A
Yield on cost (5-Year)	0.03	CI's Yield on cost (5-Year) is ranked lower than 100% of the 32 Companies in the Global Health Care Plans industry. ( Industry Median: 5.84 vs. CI: 0.03 ) Ranked among companies with meaningful Yield on cost (5-Year) only.	CI' s Yield on cost (5-Year) Range Over the Past 10 Years Min: 0.02 Med: 0.08 Max: 0.57 Current: 0.03 0.02 - 0.57
3-Year Average Share Buyback Ratio	3.50	CI's 3-Year Average Share Buyback Ratio is ranked higher than 85% of the 20 Companies in the Global Health Care Plans industry. ( Industry Median: 0.20 vs. CI: 3.50 ) Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.	CI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years Min: -5.8 Med: 4.6 Max: 11.7 Current: 3.5 -5.8 - 11.7

Valuation & Return

		vs industry	vs history
Price/Tangible Book	4.77	CI's Price/Tangible Book is ranked lower than 64% of the 14 Companies in the Global Health Care Plans industry. ( Industry Median: 4.01 vs. CI: 4.77 ) Ranked among companies with meaningful Price/Tangible Book only.	CI' s Price/Tangible Book Range Over the Past 10 Years Min: 1.46 Med: 4.2 Max: 28 Current: 4.77 1.46 - 28
Price/Projected FCF	1.07	CI's Price/Projected FCF is ranked higher than 50% of the 20 Companies in the Global Health Care Plans industry. ( Industry Median: 1.08 vs. CI: 1.07 ) Ranked among companies with meaningful Price/Projected FCF only.	CI' s Price/Projected FCF Range Over the Past 10 Years Min: 0.29 Med: 0.84 Max: 4.89 Current: 1.07 0.29 - 4.89
Price/DCF (Earnings Based)	1.24	CI's Price/DCF (Earnings Based) is ranked higher than 67% of the 9 Companies in the Global Health Care Plans industry. ( Industry Median: 1.34 vs. CI: 1.24 ) Ranked among companies with meaningful Price/DCF (Earnings Based) only.	N/A
Price/Median PS Value	1.44	CI's Price/Median PS Value is ranked lower than 83% of the 24 Companies in the Global Health Care Plans industry. ( Industry Median: 1.08 vs. CI: 1.44 ) Ranked among companies with meaningful Price/Median PS Value only.	CI' s Price/Median PS Value Range Over the Past 10 Years Min: 0.36 Med: 1.06 Max: 3.85 Current: 1.44 0.36 - 3.85
Price/Peter Lynch Fair Value	1.35	CI's Price/Peter Lynch Fair Value is ranked lower than 60% of the 10 Companies in the Global Health Care Plans industry. ( Industry Median: 1.16 vs. CI: 1.35 ) Ranked among companies with meaningful Price/Peter Lynch Fair Value only.	CI' s Price/Peter Lynch Fair Value Range Over the Past 10 Years Min: 0.35 Med: 0.61 Max: 2.96 Current: 1.35 0.35 - 2.96
Price/Graham Number	2.06	CI's Price/Graham Number is ranked higher than 56% of the 9 Companies in the Global Health Care Plans industry. ( Industry Median: 2.09 vs. CI: 2.06 ) Ranked among companies with meaningful Price/Graham Number only.	CI' s Price/Graham Number Range Over the Past 10 Years Min: 0.85 Med: 1.62 Max: 3.75 Current: 2.06 0.85 - 3.75
Earnings Yield (Greenblatt) (%)	8.46	CI's Earnings Yield (Greenblatt) (%) is ranked higher than 62% of the 24 Companies in the Global Health Care Plans industry. ( Industry Median: 7.20 vs. CI: 8.46 ) Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.	CI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years Min: 5.6 Med: 12.05 Max: 50506.3 Current: 8.46 5.6 - 50506.3
Forward Rate of Return (Yacktman) (%)	19.32	CI's Forward Rate of Return (Yacktman) (%) is ranked higher than 60% of the 15 Companies in the Global Health Care Plans industry. ( Industry Median: 18.02 vs. CI: 19.32 ) Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.	CI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years Min: -2.2 Med: 19.3 Max: 50.6 Current: 19.32 -2.2 - 50.6

More Statistics

Revenue (TTM) (Mil) $	39,252
EPS (TTM) $	7.37
Beta	0.40
Short Percentage of Float	0.48%
52-Week Range $	115.03 - 150.69
Shares Outstanding (Mil)	256.87

Analyst Estimate

	Dec16	Dec17	Dec18	Dec19
Revenue (Mil $)	39,152	40,258	41,891	45,464
EPS ($)	8.41	9.63	10.69	11.72
EPS w/o NRI ($)	8.41	9.63	10.69	11.72
EPS Growth Rate (3Y to 5Y Estimate)	8.63%
Dividends Per Share ($)	0.02	0.02

» More Articles for NYSE:CI

Headlines

Articles On GuruFocus.com

Investor Confidence in Cigna and Anthem Rises as Health Care Mergers Dealt Blows Jan 25 2017

5 Undervalued Companies With a Low Beta Dec 12 2016

52-Week Company Lows Sep 15 2016

Dodge & Cox Exits Time Warner Cable, Buys MetLife Sep 12 2016

52-Week Company Lows Sep 08 2016

5 Undervalued Companies Near 52 Week Lows Sep 02 2016

52-Week Company Lows Aug 03 2016

5 Undervalued Companies With a Low Beta Aug 03 2016

5 Companies for Defensive Investors Near 52 Week Lows Aug 02 2016

Cigna Is An Excellent Prospect, Regardless of Anthem Deal Jul 17 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Mobile App Email Alerts Referral Program Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

Value Screens

Downloads | Tools

Strategies

Market Valuation

By Country

Articles

Submit Articles

Financial Strength : 6/10

Profitability & Growth : 8/10

Financials (Next Earnings Date: 2017-05-05)

Warning Signs

Guru Trades

CI Guru Trades in Q1 2016

CI Guru Trades in Q2 2016

CI Guru Trades in Q3 2016

CI Guru Trades in Q4 2016

Insider Trades

Latest Guru Trades with CI

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Ratios

Dividend & Buy Back

Valuation & Return

More Statistics

Analyst Estimate

Headlines

Personalized Checklist

Value Screens

Downloads | Tools

Strategies

Market Valuation

By Country

Articles

Submit Articles

Financial Strength : 6/10

Profitability & Growth : 8/10

Financials .earnings_date { color: #000000; font-size: 12px; font-weight: normal; } (Next Earnings Date: 2017-05-05)

Warning Signs

Guru Trades

CI Guru Trades in Q1 2016

CI Guru Trades in Q2 2016

CI Guru Trades in Q3 2016

CI Guru Trades in Q4 2016

Insider Trades

Latest Guru Trades with CI

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Ratios

Dividend & Buy Back

Valuation & Return

More Statistics

Analyst Estimate

Headlines

Personalized Checklist

Financials (Next Earnings Date: 2017-05-05)